[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-PLRX":3,"homepage-market-summary":28,"stock-news-PLRX":169},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"PLRX","2026-10-07",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Pliant Therapeutics, Inc. Common Stock","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.","49","South San Francisco, CA",false,{"close":16,"open":17,"high":17,"low":18,"prev_close":17,"change":19,"percent_change":20,"volume":21,"transactions":22,"vwap":23,"high_52w":24,"low_52w":18,"avg_volume_52w":25,"range_52w_percent":26,"record_count":27},0.99,1.03,0.97,-0.04,-3.88,756134.600046,3022,0.9966,1.95,734280.0363158287,2,1595,{"status":29,"indices":30,"watchlist":73,"sectors":95,"benchmarks":149},"success",[31,38,45,52,58,65],{"symbol":32,"name":33,"price":34,"change":35,"pct_change":36,"is_up":14,"sparkline":37,"date":5},"SPX","S&P 500",7801.77,-17.16,-0.22,"0.0,13.9 2.3,10.5 4.6,12.4 6.9,14.2 9.3,16.0 11.6,11.5 13.9,10.8 16.2,4.8 18.5,4.8 20.8,7.9 23.2,8.0 25.5,6.0 27.8,9.1 30.1,9.8 32.4,10.8 34.7,10.0 37.1,7.0 39.4,4.4 41.7,2.0 44.0,2.9",{"symbol":39,"name":40,"price":41,"change":42,"pct_change":43,"is_up":14,"sparkline":44,"date":5},"NDX","NASDAQ 100",31160.08,-64.4,-0.21,"0.0,15.0 2.3,13.4 4.6,14.8 6.9,16.0 9.3,16.0 11.6,12.9 13.9,11.7 16.2,6.5 18.5,5.0 20.8,6.6 23.2,6.6 25.5,5.8 27.8,7.8 30.1,7.4 32.4,7.0 34.7,6.4 37.1,4.6 39.4,2.9 41.7,2.0 44.0,2.4",{"symbol":46,"name":47,"price":48,"change":49,"pct_change":50,"is_up":14,"sparkline":51,"date":5},"DJI","DOW JONES",51180,-341,-0.66,"0.0,6.3 2.3,2.0 4.6,3.3 6.9,6.0 9.3,11.3 11.6,8.7 13.9,9.5 16.2,6.4 18.5,8.0 20.8,10.9 23.2,12.3 25.5,8.2 27.8,11.2 30.1,12.3 32.4,16.0 34.7,15.8 37.1,13.7 39.4,13.0 41.7,10.8 44.0,13.7",{"symbol":53,"name":54,"price":55,"change":56,"pct_change":36,"is_up":14,"sparkline":57,"date":5},"COMP","NASDAQ Composite",27538.69,-61.2,"0.0,15.1 2.3,12.9 4.6,14.2 6.9,16.0 9.3,16.0 11.6,12.2 13.9,11.3 16.2,6.1 18.5,5.1 20.8,7.7 23.2,7.7 25.5,6.6 27.8,8.7 30.1,8.9 32.4,8.4 34.7,8.3 37.1,5.5 39.4,3.1 41.7,2.0 44.0,2.5",{"symbol":59,"name":60,"price":61,"change":62,"pct_change":63,"is_up":14,"sparkline":64,"date":5},"RUT","RUSSELL 2000",2777,-36.4,-1.29,"0.0,3.5 2.3,2.0 4.6,4.2 6.9,6.7 9.3,8.2 11.6,6.3 13.9,8.0 16.2,6.1 18.5,4.1 20.8,10.7 23.2,11.0 25.5,10.7 27.8,13.1 30.1,14.4 32.4,15.8 34.7,14.3 37.1,11.2 39.4,8.9 41.7,11.4 44.0,16.0",{"symbol":66,"name":67,"price":68,"change":69,"pct_change":70,"is_up":71,"sparkline":72,"date":5},"VIX","CBOE VIX",15.08,0.07,0.47,true,"0.0,2.0 2.3,9.7 4.6,4.9 6.9,4.5 9.3,2.5 11.6,11.3 13.9,13.7 16.2,13.5 18.5,16.0 20.8,12.3 23.2,10.4 25.5,13.5 27.8,8.8 30.1,8.9 32.4,7.8 34.7,7.6 37.1,11.8 39.4,10.9 41.7,12.9 44.0,12.6",[74,81,88],{"symbol":75,"name":76,"price":77,"change":78,"pct_change":79,"is_up":14,"sparkline":80,"date":5},"NVDA","NVIDIA Corp",237.36,-1.88,-0.79,"0.0,16.0 7.3,14.6 14.7,11.8 22.0,8.2 29.3,2.4 36.7,2.0 44.0,4.2",{"symbol":82,"name":83,"price":84,"change":85,"pct_change":86,"is_up":71,"sparkline":87,"date":5},"AAPL","Apple Inc",336.67,3.04,0.91,"0.0,16.0 7.3,9.0 14.7,14.2 22.0,7.7 29.3,9.3 36.7,7.9 44.0,2.0",{"symbol":89,"name":90,"price":91,"change":92,"pct_change":93,"is_up":14,"sparkline":94,"date":5},"TSLA","Tesla Inc",377.75,-2.93,-0.77,"0.0,16.0 7.3,15.0 14.7,15.4 22.0,7.1 29.3,3.0 36.7,2.0 44.0,3.5",[96,101,106,110,115,120,125,130,135,139,144],{"name":97,"etf":98,"change":99,"price":100,"is_up":14},"Technology","XLK",-0.3,201.39,{"name":102,"etf":103,"change":104,"price":105,"is_up":14},"Financials","XLF",-0.48,53.75,{"name":107,"etf":108,"change":17,"price":109,"is_up":71},"Healthcare","XLV",168.81,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Consumer Cycl","XLY",-0.32,111.36,{"name":116,"etf":117,"change":118,"price":119,"is_up":14},"Consumer Staples","XLP",-0.12,81.7,{"name":121,"etf":122,"change":123,"price":124,"is_up":14},"Energy","XLE",-0.58,63.38,{"name":126,"etf":127,"change":128,"price":129,"is_up":14},"Industrials","XLI",-2.18,167.84,{"name":131,"etf":132,"change":133,"price":134,"is_up":14},"Materials","XLB",-1.51,48.98,{"name":136,"etf":137,"change":63,"price":138,"is_up":14},"Real Estate","XLRE",40.57,{"name":140,"etf":141,"change":142,"price":143,"is_up":14},"Utilities","XLU",-0.02,41.15,{"name":145,"etf":146,"change":147,"price":148,"is_up":14},"Comm Services","XLC",-0.35,111.26,[150,155,160,165],{"ticker":151,"name":152,"price":153,"change":154,"is_up":14},"SPY","SPDR S&P 500 ETF",777.22,-0.24,{"ticker":156,"name":157,"price":158,"change":159,"is_up":14},"QQQ","Invesco QQQ Trust",757.73,-0.25,{"ticker":161,"name":162,"price":163,"change":164,"is_up":14},"DIA","SPDR Dow Jones ETF",511.02,-0.69,{"ticker":166,"name":167,"price":168,"change":63,"is_up":14},"IWM","iShares Russell 2000",277.7,{"ticker":4,"count":170,"articles":171},6,[172,178,184,190,195,201],{"title":173,"link":174,"pubDate":175,"description":176,"source":177},"David Raben receives a 575,000-share option at $1.05 per share from Pliant Therapeutics (PLRX). - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiuAFBVV95cUxQQlJ1bS1wMkNUV3dXa2lVWHAtUEFHV1VhTnVjcUU5c1FtYV9ReUtOWTlkZzVlcHNNdDNaSzctRzEtQzhIb01ZRHdSVExqWGtjak1USjFTekp4TXlXMlBJSkFFc1pWOFI3WWhKcDcteUFLRS1zZDZSR05TQkp3RF9VWEFwblNpbzJCYmRZYmZfWFdPZ2JfSTVFSkFteU9RRGJWYkxiQ3hpaWp1eUJUSjY1ZEN5ckFJaExU?oc=5","Fri, 02 Oct 2026 20:20:52 GMT","David Raben receives a 575,000-share option at $1.05 per share from Pliant Therapeutics (PLRX). Stock Titan","Stock Titan",{"title":179,"link":180,"pubDate":181,"description":182,"source":183},"PLRX Oct 2026 1.000 put (PLRX261016P00001000) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZkFVX3lxTFAxVUxzRHptQUFMU3ppcFpjMXVmaTRKRm55MmE5LTROQU0tbW9qbTBmeHo3eDU3STlUbVRQUE1mUThmaEx3VUw2clRNdVVaTDBlTTROc2VEeTJ3Q0RHcDNYX0NoQnJaZw?oc=5","Tue, 06 Oct 2026 20:55:19 GMT","PLRX Oct 2026 1.000 put (PLRX261016P00001000) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":185,"link":186,"pubDate":187,"description":188,"source":189},"Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer - markets.businessinsider.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixwFBVV95cUxQMFM5Z2djNkM0NlYxNVNJOHk0eVVGRjJtQ2Q2R2xaNWhqdTJ4aTJwd3JWZkVtaVc2VzV6Yk93dFJkSzc0c3dRbkJYQzFlSjZfcUtSYzhob01KY2xLeWZFUUlzSnEtSVRPYS1jRW9GTjdLM25ia0RmQTNtRmExaEFwdWZWOWtOSHJpeVZEOTIzaC1yUFZ1WFlJUkxBTVhtNG9jeHlyeUZCLVpFZW9IcUx5Xy1vTEttWmhEWk8yNlhNMXZUQkgteGMw?oc=5","Wed, 30 Sep 2026 20:35:55 GMT","Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer markets.businessinsider.com","markets.businessinsider.com",{"title":191,"link":192,"pubDate":193,"description":194,"source":177},"[Form 3] PLIANT THERAPEUTICS, INC. Initial Statement of Beneficial Ownership - Stock Titan","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxNU0NkbE5RbXJKaWRsVGdHbk5KZm0waktwbjV3S0JPalZBZzRwaHJ0S2s3ZGV0Nk9JVjVnQzE1NkxRVFZ6NHM0ekFjdF94eklXdVJxT25ISmZ2dk0zQVRLWXVLZ2NEeGZpblZwVHdveGFNUGhEd3ppWDg3NTNqMWl6MHMwdzJmUkJ0cFFvYWRWLTNMbWZveFZ6Y3JQQnZuREZmTXJtV0VCeEM5VklqT0Nna014TlVwdkZjeldER2xyWkdnSmdQV2thLXhTVQ?oc=5","Fri, 02 Oct 2026 20:19:47 GMT","[Form 3] PLIANT THERAPEUTICS, INC. Initial Statement of Beneficial Ownership Stock Titan",{"title":196,"link":197,"pubDate":198,"description":199,"source":200},"Pliant Therapeutics names David Raben as chief medical officer By Investing.com - Investing.com Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxNbmZFMVBUU3lXN1J3aUhqWUlUU2Myd0EyWFhzSHNqOWtHNXM2d2VYNGJsMGpPbWtqOHlVVDFUZkp1NHh0bUVDSDZXNkdKU1p3TmhkSk83WGg2cDJ0VVpkd2pROGtVWmRTbFBmSEp5bk9oTnAxWlQtN0x1NFVnZ1VSNGJWMWxrbTM5cUNwQVNtd0lJUVJnaFl2bEoyOTFPTmlFNUVzWVROdi10N2ZnZHE0OGZWVThjeFBrTHVkS2VwVEo?oc=5","Wed, 30 Sep 2026 21:06:20 GMT","Pliant Therapeutics names David Raben as chief medical officer By Investing.com Investing.com Canada","Investing.com Canada",{"title":202,"link":203,"pubDate":204,"description":205,"source":206},"PLRX’s FORTIFY Trial: Early Oncology Bet With Upside for Immune-Oncology Investors - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMizAFBVV95cUxQVWVpTXdBTmZqdEh0NXdLaHc1MlRVc0drUXZNLU5ERmFycG9jQTQ2NE1fRWVtam9SOUFfelVuMFNsY1JVUEl2MnZ1a0psdkYxd2VUUENSQWY1SC1Pektqc0tfUTZ3Q0NtY0UzUnQzekNOOGFQaTh6LVhCMkJ3dzlmcnVqNnpiRnFtbFNTUWM1Q1lUT2Z5WWVocEVUUmR4UVJvZTJkc1JpVU10aHdVTC1MOHRaUjZ3YXluYUV3UU9KUWtaTzRDNzFXTGFuRVg?oc=5","Fri, 02 Oct 2026 16:42:24 GMT","PLRX’s FORTIFY Trial: Early Oncology Bet With Upside for Immune-Oncology Investors TipRanks","TipRanks"]